Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).| Product Name | Nogo B |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | 1110020G17Rik antibody AA407876 antibody AA409940 antibody AA960376 antibody ASY antibody C130026I10Rik antibody Foocen antibody Glut4 vesicle 20 kDa protein antibody Human NogoA antibody Kiaa0886 antibody KIAA4153 antibody MGC116054 antibody MGC139261 antibody mKIAA0886 antibody mKIAA4153 antibody My043 protein antibody Nbla00271 antibody Nbla10545 antibody Neurite growth inhibitor 220 antibody Neurite Growth Inhibitor 220, included antibody Neurite outgrowth inhibitor antibody Neuroendocrine-specific protein antibody Neuroendocrine-specific protein C homolog antibody NI-250 antibody NI220/250 antibody Nogo A antibody NOGO antibody Nogo B antibody Nogo C antibody Nogo protein antibody NOGOC antibody NSP antibody NSP-CL antibody rat N antibody Reticulon 4 antibody Reticulon 5 antibody Reticulon-4 antibody Reticulon-5 antibody RTN X antibody RTN-x antibody Rtn4 antibody Rtn4 reticulon 4 antibody RTN4-A antibody RTN4-B1 antibody RTN4-B2 antibody RTN4-C antibody RTN4_HUMAN antibody Vp20 antibody |
| Product description | Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS. Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex. Isoform 2 reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration. Isoform 2 and isoform 3 inhibit BACE1 activity and amyloid precursor protein processing. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG |
| Host Species | Recombinant rabbit |
| Tested Applications | WBICC/IFIHCIPFC |
| WB:1:500-1:2,000 ICC/IF:1:50-1:200 IHC:1:50-1:200 FC:1:50-1:100 IP:1:10-1:50 |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Alternative Names | 1110020G17Rik antibody
AA407876 antibody
AA409940 antibody
AA960376 antibody
ASY antibody
C130026I10Rik antibody
Foocen antibody
Glut4 vesicle 20 kDa protein antibody
Human NogoA antibody
Kiaa0886 antibody
KIAA4153 antibody
MGC116054 antibody
MGC139261 antibody
mKIAA0886 antibody
mKIAA4153 antibody
My043 protein antibody
Nbla00271 antibody
Nbla10545 antibody
Neurite growth inhibitor 220 antibody
Neurite Growth Inhibitor 220 included antibody Neurite outgrowth inhibitor antibody Neuroendocrine-specific protein antibody Neuroendocrine-specific protein C homolog antibody NI-250 antibody NI220/250 antibody Nogo A antibody NOGO antibody Nogo B antibody Nogo C antibody Nogo protein antibody NOGOC antibody NSP antibody NSP-CL antibody rat N antibody Reticulon 4 antibody Reticulon 5 antibody Reticulon-4 antibody Reticulon-5 antibody RTN X antibody RTN-x antibody Rtn4 antibody Rtn4 reticulon 4 antibody RTN4-A antibody RTN4-B1 antibody RTN4-B2 antibody RTN4-C antibody RTN4_HUMAN antibody Vp20 antibody |
|---|---|
| Cellular Localization | Endoplasmic reticulum membrane. |
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).
Application
Fig9: Flow cytometric analysis of Hela cells with Nogo antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).| Positive Control | Mouse skeletal muscle tissue lysate, HepG2, Hela, A549, SH-SY5Y, human breast tissue, human fetal skeletal muscle tissue, mouse testis tissue, mouse brain tissue. |
|---|---|
| Application Notes | WB:1:500-1:2,000 ICC/IF:1:50-1:200 IHC:1:50-1:200 FC:1:50-1:100 IP:1:10-1:50 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
